SLC16A1 and glioma: Consistent with the bioinformatics analysis, the results indicated increased protein expressions of LDHA and MCT1 in gliomas compared to peri-tumorous normal tissues (Peri-NT), with notably higher levels in glioblastomas (GBM) compared to low-grade gliomas (LGG) (Fig. 1C).